Jed Alan Hummel MD, Presenter: Nothing to Disclose

Ikponmwosa Iyamu MD, Abstract Co-Author: Nothing to Disclose

Samir Kulkarni MD, Abstract Co-Author: Nothing to Disclose

Joseph Stephen Zerr MD, Abstract Co-Author: Nothing to Disclose

Anil Kumar Pillai MD, Abstract Co-Author: Nothing to Disclose

Sanjeeva P. Kalva MD, Abstract Co-Author: Consultant, CeloNova BioSciences, Inc

To discuss toxic vasculopathies with illustrative case examples The presentation will cover etiologies including cocaine, amphetamine, and heroin related vasculopathies, ergotism, chemotherapy, and thromboangiitis obliterans To briefly review the basic underlying pathophysiology of vasculitides, utilizing graphic illustration and case examples aimed at allowing the reader to better understand the mechanism that produces angiographic characteristics To review grading and classification of vasculitides based on diagnostic features including location, vessel size, and morphological appearance To review differential diagnoses and distinguishing features To discuss most appropriate imaging modalities To discuss catheter-directed therapy considerations  

Introduction: Review of features and basic pathophysiology of vasculitides with illustrative case examples Diagnostic clues regarding vessel size and location Angiographic appearances with case examples Grading and classification Discussion: Toxic Vasculopathies Etiologies Common and distinguishing imaging characteristics with discussion of differential diagnoses and potential mimics Clinical presentations Selection of best imaging modalities Catheter directed therapy considerations  

http://abstract.rsna.org/uploads/2014/14016161/14016161_cok3.pdf

Hummel, J, Iyamu, I, Kulkarni, S, Zerr, J, Pillai, A, Kalva, S, Vascular Imaging of Toxic Vasculopathies.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14016161.html